Literature DB >> 27650452

Treatment for long bone metastases based on a systematic literature review.

Costantino Errani1, Andreas F Mavrogenis2, Luca Cevolani1, Silvia Spinelli3, Andrea Piccioli3, Giulio Maccauro4, Nicola Baldini1, Davide Donati1.   

Abstract

PURPOSE: To provide treatment guidelines for patients with long bone metastatic disease based on a systematic review of the literature and to propose an algorithm to guide orthopedic surgeons in decision-making for these patients.
MATERIALS AND METHODS: We performed a computerized literature search in MEDLINE, EMBASE and Scopus for studies on patients with long bone metastases. We used the key words "long bones", "metastasis" and "treatment" for published studies that evaluated any treatment for long bone metastases. The articles found were then studied to determine the accuracy of surgical treatments for long bone metastases in every anatomic location, regardless of cancer type, stage and grade of the oncologic disease. Guidelines inferred from this literature review were collected, and an algorithm was proposed.
RESULTS: There was no clear evidence to support excision of a long bone metastatic lesion at the same surgical setting with internal fixation or prosthetic reconstruction. However, en bloc resection of an isolated bone metastasis may have a beneficial effect on survival. The life expectancy of the patients should be considered for any surgical treatment. Internal fixation preferably with reconstruction nails is indicated for meta-diaphyseal lesions; their rate of mechanical failure and complications ranges from 2 to 22 %. Prosthetic reconstruction is indicated for extensive lytic lesions or pathologic fractures in a meta-epiphyseal locations; their rate of mechanical failure and complications ranges from 3.7 to 35 %. Most of the internal fixation-related complications occur more than 1 year after treatment, in contrast to prosthetic reconstruction-related complications that may occur earlier.
CONCLUSIONS: Intramedullary nail fixation or prosthetic reconstruction should be chosen on the basis of the location of the lesion, the extent of bone destruction and the stability of the construct to outlast the expected life of the patient. Implant-related complication is similar but may occur earlier with prosthetic reconstructions.

Entities:  

Keywords:  Long bones; Metastatic bone disease; Surgical treatment

Mesh:

Year:  2016        PMID: 27650452     DOI: 10.1007/s00590-016-1857-9

Source DB:  PubMed          Journal:  Eur J Orthop Surg Traumatol        ISSN: 1633-8065


  47 in total

1.  Cemented endoprosthetic replacement for metastatic bone disease in the proximal femur.

Authors:  Hakan Selek; Kerem Başarir; Yusuf Yildiz; Yener Sağlik
Journal:  J Arthroplasty       Date:  2007-09-24       Impact factor: 4.757

2.  Survival in patients operated on for pathologic fracture: implications for end-of-life orthopedic care.

Authors:  Saminathan S Nathan; John H Healey; Danilo Mellano; Bang Hoang; Isobel Lewis; Carol D Morris; Edward A Athanasian; Patrick J Boland
Journal:  J Clin Oncol       Date:  2005-09-01       Impact factor: 44.544

3.  Metastases of the pelvis: does resection improve survival?

Authors:  Pietro Ruggieri; Andreas F Mavrogenis; Andrea Angelini; Mario Mercuri
Journal:  Orthopedics       Date:  2011-07-07       Impact factor: 1.390

4.  Economic burden of metastatic bone disease in the U.S.

Authors:  Kathy L Schulman; Joseph Kohles
Journal:  Cancer       Date:  2007-06-01       Impact factor: 6.860

Review 5.  Endoprosthetic proximal femur replacement: metastatic versus primary tumors.

Authors:  Benjamin K Potter; Vincent E Chow; Sheila C Adams; G Douglas Letson; H Thomas Temple
Journal:  Surg Oncol       Date:  2008-10-02       Impact factor: 3.279

6.  Bipolar proximal femoral replacement prostheses for musculoskeletal neoplasms.

Authors:  Joseph L Finstein; Joseph J King; Edward J Fox; Christian M Ogilvie; Richard D Lackman
Journal:  Clin Orthop Relat Res       Date:  2007-06       Impact factor: 4.176

7.  Survival after surgery for spinal and extremity metastases. Prognostication in 241 patients.

Authors:  H C Bauer; R Wedin
Journal:  Acta Orthop Scand       Date:  1995-04

8.  Superiority of denosumab to zoledronic acid for prevention of skeletal-related events: a combined analysis of 3 pivotal, randomised, phase 3 trials.

Authors:  Allan Lipton; Karim Fizazi; Alison T Stopeck; David H Henry; Janet E Brown; Denise A Yardley; Gary E Richardson; Salvatore Siena; Pablo Maroto; Michael Clemens; Boris Bilynskyy; Veena Charu; Philippe Beuzeboc; Michael Rader; Maria Viniegra; Fred Saad; Chunlei Ke; Ada Braun; Susie Jun
Journal:  Eur J Cancer       Date:  2012-09-10       Impact factor: 9.162

9.  New prognostic factors and scoring system for patients with skeletal metastasis.

Authors:  Hirohisa Katagiri; Rieko Okada; Tatsuya Takagi; Mitsuru Takahashi; Hideki Murata; Hideyuki Harada; Tetsuo Nishimura; Hirofumi Asakura; Hirofumi Ogawa
Journal:  Cancer Med       Date:  2014-07-10       Impact factor: 4.452

10.  Modular prostheses in the treatment of proximal humerus metastases: review of 40 cases.

Authors:  C Scotti; F Camnasio; G M Peretti; F Fontana; G Fraschini
Journal:  J Orthop Traumatol       Date:  2008-03-13
View more
  26 in total

1.  Internal fixation versus endoprosthetic replacement of the proximal femur for metastatic bone disease: Single institutional outcomes.

Authors:  Charles A Gusho; Bishir Clayton; Nabil Mehta; Wassim Hmeidan; Matthew W Colman; Steven Gitelis; Alan T Blank
Journal:  J Orthop       Date:  2021-11-08

Review 2.  What's new in the management of metastatic bone disease.

Authors:  Shinji Tsukamoto; Costantino Errani; Akira Kido; Andreas F Mavrogenis
Journal:  Eur J Orthop Surg Traumatol       Date:  2021-10-13

3.  Trends in Diagnosis and Surgical Treatment of Bone Metastases among Orthopedic Surgeons.

Authors:  Dawid Ciechanowicz; Daniel Kotrych; Filip Dąbrowski; Tomasz Mazurek
Journal:  J Clin Med       Date:  2022-07-23       Impact factor: 4.964

4.  Megaprosthesis for Metastatic Bone Disease-A Comparative Analysis.

Authors:  Joachim Thorkildsen; Thale Asp Strøm; Nils Jørgen Strøm; Simen Sellevold; Ole-Jacob Norum
Journal:  Curr Oncol       Date:  2022-05-10       Impact factor: 3.109

Review 5.  The role of surgery in the treatment of metastatic bone tumor.

Authors:  Katsuhiro Hayashi; Hiroyuki Tsuchiya
Journal:  Int J Clin Oncol       Date:  2022-02-28       Impact factor: 3.850

6.  Carbon/PEEK nails: a case-control study of 22 cases.

Authors:  Federico Sacchetti; Lorenzo Andreani; Michele Palazzuolo; Stephane Cherix; Enrico Bonicoli; Elisabetta Neri; Rodolfo Capanna
Journal:  Eur J Orthop Surg Traumatol       Date:  2019-12-21

Review 7.  Molecular mechanisms and clinical management of cancer bone metastasis.

Authors:  Manni Wang; Fan Xia; Yuquan Wei; Xiawei Wei
Journal:  Bone Res       Date:  2020-07-29       Impact factor: 13.567

8.  Is a single dose of preoperative antibiotic therapy effective for patients treated with megaendoprosthesis after metastatic bone tumour resection?

Authors:  M Kiran; J Alsousou; N Dalal; P Ralte; G Kumar; B Kapoor
Journal:  Musculoskelet Surg       Date:  2021-01-05

9.  Prediction of survival after surgical management of femoral metastatic bone disease - A comparison of prognostic models.

Authors:  Charles Meares; Alexander Badran; David Dewar
Journal:  J Bone Oncol       Date:  2019-02-13       Impact factor: 4.072

Review 10.  A scoping review on the surgical management of metastatic bone disease of the extremities.

Authors:  Joseph K Kendal; Annalise Abbott; Sahil Kooner; Herman Johal; Shannon K T Puloski; Michael J Monument
Journal:  BMC Musculoskelet Disord       Date:  2018-08-06       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.